Student Research Committee, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Department of General Surgery, School of Medicine, Surgical Oncology Research Center, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Obes Surg. 2023 Dec;33(12):4070-4079. doi: 10.1007/s11695-023-06846-2. Epub 2023 Oct 25.
This systematic review of 10 studies aimed to investigate the mid- and long-term results of duodeno-ileostomy with sleeve gastrectomy (SADI-S) according to the PRISMA guideline. Related articles, which reported outcomes of laparoscopic SADI-S with follow-up ≥ 3 years, were selected and analyzed. The percentage of excess weight loss (EWL) was 70.9-88.7%, and 80.4% at 6, and 10 years, respectively. The more common late complications were malabsorption (6.3%) and gastroesophageal reflux disease (GERD) (3.6%). The remission rates of hypertension, diabetes, GERD, obstructive sleep apnea, and dyslipidemia were 62.9%, 81.3%, 53.2%, 60.9%, and 69.7%, respectively. In conclusion, SADI-S is a safe and effective surgical technique with durable weight loss and a high rate of comorbidity resolution in mid and long term.
这篇系统评价纳入了 10 项研究,旨在根据 PRISMA 指南调查胃旁路袖状切除术(SADI-S)加十二指肠空肠吻合术的中远期结果。选择并分析了报告腹腔镜 SADI-S 随访时间≥3 年结果的相关文章。超重减轻率(EWL)为 70.9%-88.7%,分别为术后 6 年和 10 年的 80.4%。较常见的晚期并发症为吸收不良(6.3%)和胃食管反流病(GERD)(3.6%)。高血压、糖尿病、GERD、阻塞性睡眠呼吸暂停和血脂异常的缓解率分别为 62.9%、81.3%、53.2%、60.9%和 69.7%。总之,SADI-S 是一种安全有效的手术技术,在中远期可持久减轻体重,并能有效解决多种合并症。